CopyMark Law Group
4.9/5
Drawing for OBSEGONE

USPTO serial 79435559

OBSEGONE

Reviewed by CopyMark Law Group

Reg. 8445773Status 700Registered
Filing date
Status date
Registration date
Sep 22, 2026
Examiner
HAN, DAWN L
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with OBSEGONE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John H. Mutchler

John H. Mutchler Robinson & Cole LLPOne State StreetHartford, CT 06103United States

Goods and services

ClassDescriptionStatusFirst use
005Drugs for medical purposes, namely, medical preparations for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); medical preparation for treating alcoholic fatty liver; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of alzheimer's disease; herbal tea for medical purposes; injectable medicinal solutions, namely, injectable pharmaceuticals for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); slimming pills; appetite suppressant pills; pharmaceutical preparations for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); cardiovascular pharmaceuticals for medical use; medicines for human purposes, namely, medicinal preparations for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); appetite suppressants for medical purposes; biological preparations for medical purposes for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); medical preparations for slimming purposes; medical preparation for treating diabetes; slimming tea for medical purposes; antidiabetic pharmaceuticals; antidiabetic preparation; cardiovascular pharmaceutical preparations; lipotropic factor preparation; dietetic supplements adapted for medical use; diabetic bread adapted for medical use; dietetic beverages featuring fruit juices with pulp adapted for medical purposes, for use by diabetic patientsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 22, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 22, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 4, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 4, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 29, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 2, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 2, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 2, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Jul 2, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 2, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 3, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 3, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 3, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 1, 2026RFNTREFUSAL PROCESSED BY IB—
Dec 17, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 17, 2025RFRRREFUSAL PROCESSED BY MPU—
Nov 27, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 8, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 7, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 2, 2025DOCKASSIGNED TO EXAMINER—
Nov 1, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 1, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 30, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance